Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Management
Corporate Directory
Products
DAYBUE™ (trofinetide)
Pipeline
Pipeline
Trofinetide
Rett Syndrome
Fragile X Syndrome
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Prader-Willi Syndrome
Science
Science Behind Neuren's Products
Scientific Presentations
Publications
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Jun 05, 2013
FDA Fast Track granted for NNZ2566 Rett program
May 29, 2013
Change of Director's Interest Notice
May 29, 2013
Appendix 3B Equity Performance Rights
May 29, 2013
Appendix 3B Loan Funded Shares
May 29, 2013
Notice under section 708A(5)(e) of the Corporations Act
May 24, 2013
CFO appointment
May 22, 2013
Final Director's Interest Notice
May 22, 2013
Final Director's Interest Notice
May 22, 2013
Appendix 3B Exercise of Options
May 22, 2013
Lapse of Unlisted Options
Previous
1
2
3
4
5
6
7
8
Next